Zacks: Hanwha Q Cells Co. Ltd. (HQCL) Receives Average Rating of “Hold” from Brokerages
Shares of Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL) have earned a consensus broker rating score of 3.00 (Hold) from the one analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation. Hanwha Q Cells Co.’s rating score has declined by 200% from three months ago as a result of various analysts’ upgrades and downgrades.
Brokers have set a 1-year consensus target price of $13.00 for the company and are anticipating that the company will post $0.21 EPS for the current quarter, according to Zacks. Zacks has also given Hanwha Q Cells Co. an industry rank of 112 out of 265 based on the ratings given to related companies.
Several brokerages recently commented on HQCL. Zacks Investment Research lowered Hanwha Q Cells Co. from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 20th. Roth Capital downgraded Hanwha Q Cells Co. from a “buy” rating to a “neutral” rating in a research report on Friday, August 5th.
Hanwha Q Cells Co. (NASDAQ:HQCL) opened at 11.64 on Tuesday. The stock’s 50 day moving average price is $11.55 and its 200 day moving average price is $12.90. The company has a market capitalization of $968.24 million, a price-to-earnings ratio of 5.30 and a beta of 2.21. Hanwha Q Cells Co. has a 12 month low of $10.35 and a 12 month high of $28.87.
Hanwha Q Cells Co. (NASDAQ:HQCL) last issued its quarterly earnings data on Tuesday, August 23rd. The company reported $0.92 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.48 by $0.44. Hanwha Q Cells Co. had a return on equity of 42.12% and a net margin of 8.03%. The company earned $638 million during the quarter, compared to analyst estimates of $646 million. During the same quarter in the previous year, the company posted ($0.17) earnings per share. Hanwha Q Cells Co.’s revenue was up 88.8% compared to the same quarter last year. Equities research analysts anticipate that Hanwha Q Cells Co. will post $1.67 earnings per share for the current fiscal year.
Several hedge funds have recently made changes to their positions in HQCL. Guggenheim Capital LLC raised its stake in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock worth $7,108,000 after buying an additional 107,408 shares during the last quarter. Walleye Trading LLC raised its stake in shares of Hanwha Q Cells Co. by 1,166.7% in the second quarter. Walleye Trading LLC now owns 7,600 shares of the company’s stock worth $109,000 after buying an additional 7,000 shares during the last quarter. AJO LP purchased a new stake in shares of Hanwha Q Cells Co. during the second quarter worth about $171,000. Oxford Asset Management purchased a new stake in shares of Hanwha Q Cells Co. during the second quarter worth about $392,000. Finally, Barclays PLC purchased a new stake in shares of Hanwha Q Cells Co. during the first quarter worth about $432,000. Hedge funds and other institutional investors own 1.59% of the company’s stock.
Hanwha Q Cells Co. Company Profile
Hanwha Q CELLS Co, Ltd., formerly Hanwha SolarOne Co, Ltd., is a global solar energy company engaged in the manufacturing of solar modules, and the development and management of downstream solar farms. It manufactures a range of photo voltaic (PV) cells and PV modules at its manufacturing facilities in China and Malaysia using manufacturing process technologies, including those developed at its research and development facilities in Germany.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanwha Q Cells Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanwha Q Cells Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.